Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nico M Wulffraat

Showing results (21-30 of 145) with videos related to

Pageof 15
Sort By:
Orphanet Journal of Rare Diseases|February 1, 2020
Towards European harmonisation of healthcare for patients with rare immune disorders: outcome from the ERN RITA registries surveyRiccardo Papa, Andrew Cant, Christoph Klein, et al.
Rheumatology (Oxford, England)|October 29, 2013
Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritisMaja Bulatović Calasan, Lara D de Vries, Sebastiaan J Vastert, et al.
Journal of Clinical Medicine|February 11, 2023
Cross-Cultural Adaptation and Validation of the Methotrexate Intolerance Severity Score Questionnaire in Portuguese (Brazil) for Children and Adolescents with Juvenile Idiopathic ArthritisAna Carolina Londe, Jaqueline Cristina de Amorim, Paulo Rogério Julio, et al.
The Journal of Pediatrics|April 23, 2022
A Diagnostic Prediction Model for Separating Juvenile Idiopathic Arthritis and Chronic Musculoskeletal Pain SyndromeJoeri W van Straalen, Martine van Stigt Thans, Nico M Wulffraat, et al.
Pediatric Rheumatology Online Journal|August 22, 2012
Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)Philomine A van Pelt, Tim Takken, Marco van Brussel, et al.
Pediatric Rheumatology Online Journal|August 29, 2012
Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)Philomien A van Pelt, Tim Takken, Marco van Brussel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort studySebastiaan J Vastert, Wilco de Jager, Bo Jan Noordman, et al.
Annals of the Rheumatic Diseases|December 16, 2006
Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional studyWilco de Jager, Esther P A H Hoppenreijs, Nico M Wulffraat, et al.
The Lancet. Rheumatology|June 14, 2024
The outcomes of children born to mothers with autoimmune rheumatic diseasesLaura Andreoli, Jeanette Andersen, Tadej Avcin, et al.
Rheumatology (Oxford, England)|April 20, 2021
Association of adalimumab trough concentrations and treatment response in patients with juvenile idiopathic arthritisMartijn J H Doeleman, Sytze de Roock, Mohsin El Amrani, et al.
Pageof 15

Showing results (21-30 of 145) with videos related to

Sort By:
Pageof 15
Orphanet Journal of Rare Diseases|February 1, 2020
Towards European harmonisation of healthcare for patients with rare immune disorders: outcome from the ERN RITA registries surveyRiccardo Papa, Andrew Cant, Christoph Klein, et al.
Rheumatology (Oxford, England)|October 29, 2013
Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritisMaja Bulatović Calasan, Lara D de Vries, Sebastiaan J Vastert, et al.
Journal of Clinical Medicine|February 11, 2023
Cross-Cultural Adaptation and Validation of the Methotrexate Intolerance Severity Score Questionnaire in Portuguese (Brazil) for Children and Adolescents with Juvenile Idiopathic ArthritisAna Carolina Londe, Jaqueline Cristina de Amorim, Paulo Rogério Julio, et al.
The Journal of Pediatrics|April 23, 2022
A Diagnostic Prediction Model for Separating Juvenile Idiopathic Arthritis and Chronic Musculoskeletal Pain SyndromeJoeri W van Straalen, Martine van Stigt Thans, Nico M Wulffraat, et al.
Pediatric Rheumatology Online Journal|August 22, 2012
Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)Philomine A van Pelt, Tim Takken, Marco van Brussel, et al.
Pediatric Rheumatology Online Journal|August 29, 2012
Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)Philomien A van Pelt, Tim Takken, Marco van Brussel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort studySebastiaan J Vastert, Wilco de Jager, Bo Jan Noordman, et al.
Annals of the Rheumatic Diseases|December 16, 2006
Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional studyWilco de Jager, Esther P A H Hoppenreijs, Nico M Wulffraat, et al.
The Lancet. Rheumatology|June 14, 2024
The outcomes of children born to mothers with autoimmune rheumatic diseasesLaura Andreoli, Jeanette Andersen, Tadej Avcin, et al.
Rheumatology (Oxford, England)|April 20, 2021
Association of adalimumab trough concentrations and treatment response in patients with juvenile idiopathic arthritisMartijn J H Doeleman, Sytze de Roock, Mohsin El Amrani, et al.
Pageof 15